Risk of Fracture With Dipeptidyl Peptidase-4 Inhibitors, Glucagon-like Peptide-1 Receptor Agonists, or Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Network Meta-analysis Combining 177 Randomized Controlled Trials With a Median Follow-Up of 26 weeks

• Hauptverfasser: Sanbao Chai (Verfasst von), Fengqi Liu (Verfasst von), Zhirong Yang (Verfasst von), Shuqing Yu (Verfasst von), Zuoxiang Liu (Verfasst von), Qingqing Yang (Verfasst von), Feng Sun (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Aim: This study aims to investigate the association between the use of dipeptidyl peptidase-4 inhibitors (DPP-4i), glucagon-like peptide-1 receptor agonists (GLP-1 RAs), or sodium-glucose cotransporter-2 inhibitors (SGLT-2i) and the risk of fracture among patients with type 2 diabetes mellitus.Metho...